Discover the Best CRO Model to Use for Decentralized Trials
Decentralized clinical trials (DCTs) have grown substantially over the past few years. Today’s biopharma companies are increasingly leaning on virtual tools to make remote trials a fixed part of their portfolios. This expanding footprint in turn enables anyone, anywhere, to participate in a clinical trial.
As sponsors make sense of the new tech ecosystem supporting remote trials, they’re encountering a critical question: should they structure their DCT portfolio as a full-service approach (all-in-one), or one that engages best-of-breed/functional service providers (FSPs)?
Designed for biopharma leaders, our playbook will unveil questions to ask when comparing DCT partners. You will discover:
The benefits of all-in-one vs. best-of-breed models
How to build a better vendor ecosystem
A new approach to CRO model selection that focuses on partner-by-partner specialty services